ATLANTA, GA — Younger, low-risk patients with aortic stenosis who need aortic valve replacement may now be able to consider a less invasive transcatheter approach rather […]

In patients with acute coronary syndrome (ACS), intravascular ultrasound (IVUS)-guided implantation of a drug-eluting stent improved outcomes compared with angiography guidance alone. “Our study included all […]

Treatment with a single subcutaneous dose of the RNA interference agent zilebesiran was associated with clinically significant reductions in systolic blood pressure compared with placebo at […]

ATLANTA — A investigative drug that uses a novel pathway to target cardiac metabolism was safe and well-tolerated and showed a signal to improve cardiac function […]

ATLANTA, GA — Despite failing to increase perfusion as hypothesized, a coronary sinus reducer (CSR) in a sham-controlled randomized trial meaningfully reduced angina and improved quality […]

Treatment with zerlasiran produced sustained reductions in lipoprotein(a) [Lp(a)] concentrations out to 1 year in adults with elevated Lp(a), extended data from the APOLLO phase 1 […]

ATLANTA — Beta-blockers have been a mainstay of therapy for patients who have revascularization after an acute myocardial infarction (MI), but people who have had smaller […]

Atlanta — A randomized transcatheter aortic valve replacement (TAVR) trial demonstrated that a self-expanding device performs better on multiple prognostically important measures of valve function at […]

In patients with severely elevated triglyceride levels who are at risk for acute pancreatitis, the investigational drug plozasiran brought about substantial reductions in triglyceride levels in […]